Clinical Takeaway Pharmaceutical-grade cannabidiol (Epidiolex) reduced drop seizure frequency in Lennox-Gastaut syndrome patients at thresholds below the traditional 50% benchmark, with caregiver-reported outcomes confirming that even smaller reductions translated to meaningful real-world...